London Genetics Limited and Astrimmune have entered into a collaboration to plan a biomarker identification programme for Astrimmune's early-stage pancreatic cancer vaccine candidate.
12 November, 2010
Researchers have taken the first steps towards understanding why a rare skin cancer that is rapidly increasing in incidence in Europe and the USA is not recognized by the body’s immune system.
08 November, 2010